Skip Navigation
Skip to contents

Cancer Res Treat : Cancer Research and Treatment

OPEN ACCESS

Search

Page Path
HOME > Search
1 "Ki Woong Kim"
Filter
Filter
Article category
Keywords
Publication year
Authors
Original Article
Five-Year Follow-up Study of Monoclonal Gammopathy of Undetermined Significance in a Korean Elderly Urban Cohort
Yun-Gyoo Lee, Soo-Mee Bang, Jeong-Ok Lee, Jin Won Kim, Keun-Wook Lee, Jee Hyun Kim, Jung Han Song, Tae-Hee Kim, Ki Woong Kim, Jong-Seok Lee
Cancer Res Treat. 2015;47(2):215-220.   Published online August 29, 2014
DOI: https://doi.org/10.4143/crt.2013.262
AbstractAbstract PDFPubReaderePub
Purpose
We previously reported the prevalence of monoclonal gammopathy of undetermined significance (MGUS) to be 3.3% among an elderly Korean urban cohort recruited during 2005-2006. Here, we report a 5-year follow-up study of the previously identified MGUS cohort.
Materials and Methods
The 680 participants from the initial cohort were followed-up for a median of 5 years. Sera were collected between 2010 and 2011. Two-step screening was performed with standard serum electrophoresis followed by immunofixation and determination of the serum concentration of monoclonal-protein (M-protein).
Results
Of the 680 participants (21 with MGUS), 348 (51%) agreed to participate in the follow-up study and 10 were found to have MGUS. Among the 21 MGUS patients initially identified, nine were followed-up, six had persistent M-protein, and one patient had progressed to multiple myeloma (progression rate, 1.0%/yr). The M-protein disappeared in the remaining two individuals. Among the 339 participants without MGUS who were followed-up, four developed an M-protein. There was no significant difference in survival with respect to the presence of MGUS (p=0.66).
Conclusion
The 5-year follow-up data show that the natural clinical course of MGUS in Korea is similar to that in Western countries. MGUS was not associated with an increased risk of death over the 5-year study period.

Citations

Citations to this article as recorded by  
  • Prevalence of monoclonal gammopathy of undetermined significance in Shenzhen, China
    Anping Xu, Tong Guo, Shuping Zhang, Houlong Luo, Mengxue Shen, Yinghui Ye, Ling Ji
    Hematology.2024;[Epub]     CrossRef
  • Isatuximab plus carfilzomib and dexamethasone in East Asian patients with relapsed multiple myeloma: IKEMA subgroup analysis
    Kihyun Kim, Chang-Ki Min, Youngil Koh, Kenichi Ishizawa, Sung-Hyun Kim, Shigeki Ito, Junji Tanaka, Michihiro Uchiyama, Yawara Kawano, Jin Seok Kim, Philippe Moreau, Thomas Martin, Yvonne Dong, Marie-Laure Risse, Kenshi Suzuki
    International Journal of Hematology.2022; 116(4): 553.     CrossRef
  • Screening Tests for Early Diagnosis of Multiple Myeloma and Related Plasma Cell Disorders
    Jin Seok Kim, Sung-Soo Yoon, Chang-Ki Min, Je-Jung Lee, Dok Hyun Yoon, Kihyun Kim
    The Korean Journal of Medicine.2021; 96(5): 371.     CrossRef
  • Prevalence of monoclonal gammopathy of undetermined significance in a large population with annual medical check-ups in China
    Jian-hua Han, Ji-nuo Wang, Yue-lun Zhang, Xin-xin Cao, Dao-bin Zhou, Teng-da Xu, Wei Su, Jian Li
    Blood Cancer Journal.2020;[Epub]     CrossRef
  • Monoclonal gammopathy of undetermined significance in Chinese population: A prospective epidemiological study
    Ling Ma, Shuang Xu, Jianhua Qu, Jian Hou, Yang Wang, Lei Wen, Yang Liu, Ying Kang, Ming Jiang, Weijun Fu, Juan Du, Lin Zhou, Xiaojun Huang, Zhaoxia Zhang, Jin Lu
    Hematological Oncology.2019; 37(1): 75.     CrossRef
  • The clinical features and prognosis of the monoclonal gammopathy undetermined significance: A single center study
    Ling Ma, Shuang Xu, Lei Wen, Yang Liu, Ying Kang, Xiaojun Huang, Jin Lu
    Blood Cells, Molecules, and Diseases.2018; 73: 9.     CrossRef
  • Recent advances in multiple myeloma: a Korean perspective
    Junshik Hong, Jae Hoon Lee
    The Korean Journal of Internal Medicine.2016; 31(5): 820.     CrossRef
  • 14,383 View
  • 86 Download
  • 6 Web of Science
  • 7 Crossref
Close layer

Cancer Res Treat : Cancer Research and Treatment
Close layer
TOP